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Abstract
Background: Although the general statistical advice is to keep continuous exposure variables as continuous in
statistical analyses, categorisation is still a common approach in medical research. In a recent paper from the
Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study, categorisation of body mass index (BMI) was used
when analysing the effect of BMI on adverse pregnancy outcomes. The lowest category, labelled “underweight”,
was used as the reference category.
Methods: The present paper gives a summary of reasons for categorisation and methodological drawbacks of this
approach. We also discuss the choice of reference category and alternative analyses. We exemplify our arguments
by a reanalysis of results from the HAPO paper.
Results: Categorisation of continuous exposure data results in loss of power and other methodological challenges.
An unfortunate choice of reference category can give additional lack of precision and obscure the interpretation of
risk estimates. A highlighted odds ratio (OR) in the HAPO study is the OR for birth weight >90
th percentile for
women in the highest compared to the lowest BMI category ("obese class III” versus “underweight”). This estimate
was OR = 4.55 and OR = 3.52, with two different multiple logistic regression models. When using the “normal
weight” category as the reference, our corresponding estimates were OR = 2.03 and OR = 1.62, respectively.
Moreover, our choice of reference category also gave narrower confidence intervals.
Summary: Due to several methodological drawbacks, categorisation should be avoided. Modern statistical analyses
should be used to analyse continuous exposure data, and to explore non-linear relations. If continuous data are
categorised, special attention must be given to the choice of reference category.
Background
Although the general statistical advice is to keep contin-
uous exposure variables as continuous in statistical ana-
lyses [1,2], categorisation of continuous variables is still
a common approach in medical research [3,4]. In the
present paper we revisit this issue, and we have chosen
to exemplify our arguments through a discussion and
reanalysis of data from the recently published paper
“Hyperglycaemia and Adverse Pregnancy Outcome
(HAPO) Study: associations with maternal body mass
index.” [5].
The main objective of the international, multicentre
HAPO study was to clarify the risk of adverse outcomes
associated with various degrees of glucose intolerance
during pregnancy, including degrees less than overt dia-
betes [6]. With its impressive sample size, double-blind-
ing of glucose levels and thoroughly developed
standardized routines for data collection, this is already a
well-cited and highly valued study in the fields of obste-
trics and endocrinology. In total, 25 505 women were
enrolled in the study from 2000 to 2006. Glucose toler-
ance was measured by a 75-g 2-h oral glucose tolerance
test (OGTT) in a large, heterogeneous, multinational,
ethnically diverse cohort of women at approximately 28
weeks of gestation. The participating women, caregivers
and HAPO staff were blinded to glucose tolerance values,
except when predefined thresholds were met. Height and
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at the OGTT visit. Both glucose tolerance and body mass
index (BMI, kg/m
2) were measured on continuous scales.
In the study protocol it is argued for a possible continu-
ous relation between glucose and pregnancy outcomes
[6]. However, in the statistical analyses, BMI was
categorised.
Our aim is to discuss arguments for categorisation of
exposure variables and the corresponding methodologi-
cal challenges of doing so. We also discuss issues that
need attention if categorisation is the strategy of choice.
Furthermore, we show how different choices of refer-
ence category can influence the results presented in the
HAPO paper. Finally, we present alternative strategies to
that of categorisation of continuous variables.
Regression analysis and linearity assumptions
The primary analytic tool in the HAPO paper [5] was
logistic regression analysis. In standard logistic regres-
sion analyses, linearity in the logit is assumed [7]. Simi-
larly, in linear regression, a linear relation is assumed
between the exposure variable and the response variable.
These assumptions give easily interpretable results for
continuous exposure variables. However, a linearity
check should always be carried out. If the observed data
fulfil the linearity assumptions, the general advice is to
keep continuous variables as continuous in such ana-
lyses [1,2]. A wide range of linearity diagnostics is avail-
able for different regression models [7]. Although we
will use logistic regression analyses from the HAPO
paper as our example, our arguments apply to other
regression models as well. The authors of the HAPO
paper have discarded a linear model with BMI as a con-
tinuous exposure variable because of a statistically sig-
nificant squared term of BMI. This is not in itself a
valid argument for rejection of a linear model, unless
additional linearity diagnostics have also been used. In
any case, presence of non-linearity must be reflected in
regression models. Several approaches are possible. The
most commonly used approach, also taken in the HAPO
paper, is to categorise the data [3,4].
The cost of categorisation of continuous data
Categorisation of continuous exposure data is intriguing
because it seems to represent a simple solution to a
methodological challenge. It is a common belief that
categorical exposure data are both more robust, i.e. not
easily affected by small departures from model assump-
tions, easier to interpret and more feasible to present
than their continuous counterparts. Categorisation also
mirrors clinical practice. Research results are crucial in
the development of clinical medical practice where deci-
sions typical are categorical in nature. The similarities
between clinical decision-making and a categorical data
analysis and presentation approach can make reading
and understanding scientific papers with categorical data
easier for clinicians. However, categorisation comes with
some costs. Firstly, there is a loss of power due to
reduced variability in the data. Several papers have
addressed this issue and simulation studies have been
used to quantify the loss [1,2]. In a study as large as the
HAPO study, there is enough information to retain suf-
ficient power even after the categorising of data. Indeed,
the sample size calculations for the HAPO study were
based on categorised data [6]. Paradoxically, one conse-
quence of large sample sizes is that even small devia-
tions from linearity can be detected, which again leads
to categorisation of the originally continuous variables,
resulting in loss of power and the need for larger sample
sizes. Secondly, categorisation conceals information
about the details of the non-linear relation. When cate-
gorising, one assumes that the relation between the
independent and the dependent variable is constant
within intervals. This implies that any change in effect
within an interval will be lost, also biologically plausible
ones. Less obvious, but also important consequences of
categorisation are those related to residual confounding
[1,2], increased risk of false positive results [1,2] and
issues about misclassification [8], which all may give
unintentionally biased results. It has been shown that
less of the confounding will be removed if one adjusts
for a categorised variable, instead of the original contin-
uous variable [1,2]. Further, choice of cut-off values can
significantly impact effect measures, e.g. odd ratios, and
can thereby lead to artificial associations between vari-
ables [1,2]. Finally, most exposure variables are prone to
measurement errors. When categorising a continuous
variable, nondifferential errors can lead to differential
misclassification [8].
Categorisation in the HAPO paper
Assuming that the choice of categorising data is made
despite of the shortcomings of such a strategy, cut-off
values and reference category must be chosen with care.
It is common to use internationally and clinically
accepted categories, if such exist. The HAPO paper [5]
f o c u s e so nB M Ia st h ee x p o s u r ev a r i a b l ef o rs e v e r a l
pregnancy outcomes. The international classification of
BMI (kg/m
2) in adults suggested by WHO [9] is “under-
weight” (<18.5), “normal weight” (18.5-24.9), “over-
weight” (25.0-29.9) and “obese class I-III” (30.0-34.9,
35.0-39.9 and ≥40, respectively). In the HAPO study,
BMI was measured only at gestational weeks 24-32 (at
the OGTT). Due to the expected weight gain during the
first 24-32 weeks of the pregnancy the WHO categories
did not readily apply. Instead, “comparable category lim-
its for BMI” at 28 weeks of gestation were estimated by
a regression analysis of BMI measured at the OGTT on
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OGTT: <22.6, 22.6-28.4, 28.5-32.9, 33.0-37.4, 37.4-41.9
and ≥42.0 kg/m
2.
This usage of regression modelling deserves a remark.
A regression model consists of two main elements; a
deterministic term, linking the exposure to the outcome,
and an error term which incorporates the residual var-
iance of the observations, which is not expressed by the
link function. This implies that one cannot merely
transform the mid-pregnancy BMI to a predicted pre-
pregnancy BMI, based on the regression estimates, as
part of the variance has been discarded when the pre-
pregnant BMI was estimated. Additionally, it is not easy
to deduct how this could influence misclassification
issues.
In statistical analysis of categorical data, the reference
category is the category against which the others are
compared [7]. Both the biological interpretation of the
estimated association and the number of observations
should be considered when choosing the reference cate-
gory. In the HAPO paper, the estimated “normal range”
BMI category at gestational week 24-32 was 22.6-28.4
kg/m
2. With its almost 12 000 (51%) women it was also
the largest group, making it the preferred reference cate-
gory both by means of a natural reference and by con-
siderations of statistical power. However, the lowest
BMI group, labelled “underweight”, with 2989 (13%)
women was chosen as the reference. This resulted in
broader confidence intervals, and somewhat misleading
effect estimates. Clinically, the underweight group is
susceptible to having additional health problems, like
eating disorders or chronic diseases influencing body
weight. Thus, there are several reasons why using the
“underweight” group as the reference could influence
the estimated associations in the HAPO study.
The HAPO paper estimated associations between BMI
and 11 different outcomes. The results were presented
as frequencies and adjusted effect estimates (odds ratios,
ORs, and 95% confidence intervals, CIs) from two differ-
ent multiple logistic regression models. The crude ORs
were not given, but can easily be calculated from the
frequencies in the tables. We have focused on the
macrosomia (high birth weight) results, and Table 1
shows results from logistic regression analyses of the
effect of BMI on macrosomia, with two different choices
of reference category. We first considered the crude
results with reference categories BMI <22.6 kg/m
2 or
BMI 22.6-28.4 kg/m
2. Although the same increasing
trend is seen, the two analyses give different impressions
to the reader. By using “underweight” as the reference
group, the increasing trend is striking, with a nearly
five-fold increased risk for macrosomia in the highest
BMI group ("obese class III”). When “normal range” is
used as the reference group, the similarities of the three
highest BMI groups are clearly seen, in addition to the
statistically significantly lower OR for the “underweight”
group. The lack of increase in ORs for the three highest
BMI groups is even more convincing for the adjusted
ORs. In addition, the table shows the standard errors of
the betas in the logistic regressions and the widths of
the unadjusted 95% CIs, illustrating the loss in statistical
power by using a small group as the reference, com-
pared to using the larger normal range group as the
reference. It should be noted that using SE for the betas
instead of CI for the ORs as measures of precision of
the estimates show much less exaggeration of lack of
Table 1 The effect of BMI on macrosomia: Different reference categories influence effect estimates and precision
Crude analysis Adjusted analysis**
HAPO model I HAPO model II
Reference
category
BMI <22.6 BMI 22.6-28.4 BMI
<22.6
BMI
22.6-28.4
BMI
<22.6
BMI
22.6-28.4
BMI (kg/
m
2)*
n Beta (SE) OR (95% CI) Width
of CI
Beta (SE) OR (95% CI) Width
of CI
OR OR OR OR
<22.6 2974 0 1.00 -0.80 (0.10) 0.45 (0.37-0.55) 0.2 1.00 0.45 1.00 0.46
22.6-28.4 11934 0.80 (0.10) 2.23 (1.83, 2.71) 0.9 0 1.00 2.24 1.00 2.17 1.00
28.5-32.9 5127 1.27 (0.10) 3.57 (2.91, 4.38) 1.5 0.47 (0.05) 1.60 (1.44-1.78) 0.3 3.62 1.62 3.31 1.52
33.0-37.4 2064 1.47 (0.11) 4.36 (3.49, 5.45) 2.0 0.67 (0.07) 1.96 (1.71-2.25) 0.5 4.43 1.98 3.89 1.79
37.5-41.9 735 1.50 (0.14) 4.47 (3.40, 5.88) 2.5 0.70 (0.11) 2.01 (1.63-2.48) 0.9 4.52 2.02 3.80 1.76
≥42.0 383 1.55 (0.17) 4.71 (3.38, 6.56) 3.2 0.75 (0.14) 2.12 (1.60-2.80) 1.2 4.55 2.03 3.52 1.62
* BMI categories are based on BMI measured at 28 weeks gestation, and the categories correspond to pre-gestational BMI categories as suggested by WHO:
“underweight” (<18.5), “normal weight” (18.5-24.9), “overweight” (25.0-29.9) and “obese class I-III” (30.0-34.9, 35.0-39.9 and ≥40, respectively) [4].
** HAPO Model I: Adjusted for the variables used in estimating 90th birth weight percentiles (gender, gestational age, ethnicity, field centre, and maternal parity),
age, height and gestational age at the oral glucose tolerance test, smoking, alcohol use, hospitalisation before delivery and any family history of diabetes. Model
II: Model I with additional adjustment for fasting plasma glucose and mean arterial pressure [4].
The table shows results from logistic regression analyses of the effect of BMI on macrosomia, with two different choices of reference category. All results are
based on the HAPO paper [4].
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most scientific papers that present results from logistic
regression focus on ORs rather than betas. We have
therefore chosen to present both, also the widths of the
CIs. By changing the reference category, the main con-
clusions in the paper would not be altered, but the
effect sizes would be relative to pregnant women with a
normal range BMI, as well as being more precisely
estimated.
Alternatives to categorisation
Application of more complex modern statistical techni-
ques is necessary if we want to keep variables continu-
ous in situations where non-linearity is evident. Suitable
statistical methods include piecewise linear regression
[10] and spline based techniques [11], for example gen-
eralised additive models (GAMs). By applying such tech-
niques, one will gain statistical power, avoid unintended
methodological challenges based on classification pro-
blems, as well as allowing the data to provide more
explicit details about the non-linear relations. This
could include apparent change-points or thresholds
values where a change in the outcome variable can be
observed, piecewise linear relations, “plateau” effects and
so on. The existence and locations of change-points can
further be formally tested for and estimated [10]. In the
HAPO paper, a plateau effect for the higher BMI cate-
gories is discussed. Both clinical practice and physiologi-
cal theories would benefit from a statistical test for the
existence of a plateau effect, and an estimate of the BMI
value where the risk levelled off. Application of more
complex analytical tools will to some extent complicate
the technical analysis and the task of applying and com-
municating the research results. However, this should
not prevent a more optimal analysis.
Summary
Applying and communicating results from statistical
analyses is a challenging aspect of the scientific process.
The results should be presented in a simple, yet
balanced manner, and should be based on adequate sta-
tistical methods. Researchers should be aware of the
trade-off between simplicity in presentation and unin-
tended methodological challenges arising from simplifi-
cations. Particularly, if one chooses to categorise
continuous exposure variables, special attention must be
given both to the definition of categories and the choice
of reference category. If we apply modern statistical ana-
lysis techniques, we might extract more detailed knowl-
edge and get a better utilisation of our data.
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